IL19 and glioblastoma: To generate an MRI contrast agent with targeting specificity for human IL-19 in GBM, we developed novel CHOL-PEG-modified SPIO nanoparticles conjugated with IL-19 antibodies as a potential biodegradable brain drug delivery system.